La Jolla Institute renews longtime collaboration with Kyowa Kirin, Inc.
The agreement marks another milestone in one of the most enduring industry-academic collaborations in the world.
Priyanka Saminathan’s inner strength
An LJI scientist shares lessons from the world of traditional Indian dance
Strange DNA structures may drive cancer development
LJI researchers shed light on the role of TET enzymes in genomic stability and cancers
Alba Grifoni receives ISSNAF award for COVID-19 research
New award from the Embassy of Italy honors an Italian scientist making breakthroughs in a global crisis
Inside the labs of three leading San Diego scientists
LA JOLLA—Studying the immune system means venturing into uncharted territory, leading explorations of the countless immune cells and genetic players
Beating HIV and COVID-19 may depend on tweaking vaccine molecules
LA JOLLA—Designing a vaccine starts with finding the right ingredients. Every infectious agent has molecules, called antigens, that the immune
T cells can shift from helping to harming in atherosclerosis
LA JOLLA—High cholesterol kills. In fact, one in four Americans will die from the consequences of atherosclerosis, the buildup of
Dengue
Dengue fever is the world’s most common mosquito-borne disease, giving rise to 390 million cases of viral disease yearly in tropical regions of Africa, Latin America, and Asia.
Croft Lab
Michael Croft, Ph.D., and his team focus on a number of molecules that are members of the tumor necrosis factor (TNF) and tumor necrosis factor receptor (TNFR) family.
Asthma
Asthma affects more than 25 million people across the nation—7 million of them children—and the incidence is rising.